Alan Ezekowitz - 27 Jun 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Gregory Tourangeau, as attorney-in-fact for Alan Ezekowitz
Issuer symbol
FULC
Transactions as of
27 Jun 2022
Transactions value $
$0
Form type
4
Filing time
29 Jun 2022, 17:00:51 UTC
Previous filing
14 Jun 2022
Next filing
13 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +19,000 $0 19,000 27 Jun 2022 Common Stock 19,000 $5.22 Direct F1
transaction FULC Stock Option (right to buy) Other $0 -500 -3.3% $0 14,500 28 Jun 2022 Common Stock 500 $11.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 27, 2022 and is scheduled to vest with respect to all shares on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to continued service.
F2 No value was received for the cancellation of these stock options, which were originally granted on December 3, 2020.

Remarks:

Exhibit Index: 24.1 Power of Attorney